Yicha - Phase 2 data suggests Rigel's fostamatinib may provide therapeutic benefit in COVID

Article: https://seekingalpha.com/news/3736028-phase-2-data-suggests-rigel-fostamatinib-may-provide-therapeutic-benefit-in-covid?source=feed_sector_healthcare